Bionano Genomics, Inc. Warrant
BNGOW
BNGOW was delisted on the 17th of August, 2023.
3 hedge funds and large institutions have $105K invested in Bionano Genomics, Inc. Warrant in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
40% less funds holding
Funds holding: 5 → 3 (-2)
45% less capital invested
Capital invested by funds: $191K → $105K (-$86K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$65K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1K |
BNGOW Hedge Fund Activity: Q3 2019 in Review
3 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics, Inc. Warrant (BNGOW) for Q3 2019, worth a combined $105K — down 45% from $191K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BNGOW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Worth Venture Partners, exiting entirely with an estimated $65K sold.
- 3 institutional investors held Bionano Genomics, Inc. Warrant (BNGOW) as of Q3 2019, down from 5 in Q2 2019.
- Funds reported $105K of Bionano Genomics, Inc. Warrant stock for Q3 2019, down 45% quarter-over-quarter.
- 0 funds opened new Bionano Genomics, Inc. Warrant positions in Q3 2019 and 2 closed out, a net change of -2 holders.
- The largest Bionano Genomics, Inc. Warrant seller in Q3 2019 was Worth Venture Partners, an estimated $65K sold.
Based on aggregated 13F filings for Q3 2019.